Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Experimental hemophilia gene therapy to progress despite adverse immune response in two patients

This week: Regeneron and bluebird join forces to develop immune-oncology therapeutics and UK trial will target Crohn’s disease

Go to the profile of RegMedNet
Aug 09, 2018
0
0

Please sign in or register for FREE

No comments yet.